CA2737004A1 - Biomarqueurs du cancer des ovaires et leurs utilisations - Google Patents

Biomarqueurs du cancer des ovaires et leurs utilisations Download PDF

Info

Publication number
CA2737004A1
CA2737004A1 CA2737004A CA2737004A CA2737004A1 CA 2737004 A1 CA2737004 A1 CA 2737004A1 CA 2737004 A CA2737004 A CA 2737004A CA 2737004 A CA2737004 A CA 2737004A CA 2737004 A1 CA2737004 A1 CA 2737004A1
Authority
CA
Canada
Prior art keywords
biomarker
ovarian cancer
individual
biomarkers
slpi
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2737004A
Other languages
English (en)
Inventor
Larry Gold
Marty Stanton
Edward N. Brody
Rachel M. Ostroff
Dominic Zichi
Alex A. E. Stewart
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Somalogic Inc
Original Assignee
Somalogic Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Somalogic Inc filed Critical Somalogic Inc
Publication of CA2737004A1 publication Critical patent/CA2737004A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57449—Specifically defined cancers of ovaries
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G16B40/20—Supervised data analysis
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Medical Informatics (AREA)
  • Data Mining & Analysis (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Artificial Intelligence (AREA)
  • Evolutionary Computation (AREA)
  • Databases & Information Systems (AREA)
  • Public Health (AREA)
  • Software Systems (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Evolutionary Biology (AREA)
  • Biophysics (AREA)
  • Bioethics (AREA)
  • Theoretical Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
CA2737004A 2008-10-06 2009-10-06 Biomarqueurs du cancer des ovaires et leurs utilisations Abandoned CA2737004A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10314908P 2008-10-06 2008-10-06
US61/103,149 2008-10-06
PCT/US2009/059706 WO2010042525A1 (fr) 2008-10-06 2009-10-06 Biomarqueurs du cancer des ovaires et leurs utilisations

Publications (1)

Publication Number Publication Date
CA2737004A1 true CA2737004A1 (fr) 2010-04-15

Family

ID=42076103

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2737004A Abandoned CA2737004A1 (fr) 2008-10-06 2009-10-06 Biomarqueurs du cancer des ovaires et leurs utilisations

Country Status (4)

Country Link
EP (1) EP2350917A4 (fr)
AU (1) AU2009302537A1 (fr)
CA (1) CA2737004A1 (fr)
WO (1) WO2010042525A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2804857C (fr) 2010-08-13 2021-07-06 Somalogic, Inc. Biomarqueurs du cancer du pancreas et leurs utilisations
US9322051B2 (en) 2013-10-07 2016-04-26 General Electric Company Probing of biological samples
WO2016025332A1 (fr) 2014-08-12 2016-02-18 President And Fellows Of Harvard College Système et procédé de surveillance de santé sur la base d'un fluide corporel collecté
WO2017180909A1 (fr) 2016-04-13 2017-10-19 Nextgen Jane, Inc. Dispositifs, systèmes et procédés de collecte et de conservation d'échantillon
US20190331686A1 (en) * 2018-04-27 2019-10-31 Laboratory Corporation Of America Holdings Methods and Systems for Determining the Risk of Developing Ovarian Cancer
CN110244733B (zh) * 2019-06-20 2020-06-30 西南交通大学 一种基于改进蚁群算法的移动机器人路径规划方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1739185A1 (fr) * 2002-12-18 2007-01-03 Ciphergen Biosystems, Inc. Biomarqueurs pour le cancer du poumon
WO2005016126A2 (fr) * 2003-08-15 2005-02-24 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Analyse multifactorielle pour la detection du cancer
JP5160447B2 (ja) * 2005-12-22 2013-03-13 アボット・ラボラトリーズ 肺がんへの傾向についてのスクリーニングのための方法およびマーカー組合せ
US20070212721A1 (en) * 2006-01-27 2007-09-13 Tripath Imaging, Inc. Methods for identifying patients with an increased likelihood of having ovarian cancer and compositions therefor

Also Published As

Publication number Publication date
AU2009302537A1 (en) 2010-04-15
WO2010042525A9 (fr) 2010-11-18
EP2350917A1 (fr) 2011-08-03
EP2350917A4 (fr) 2012-06-06
WO2010042525A1 (fr) 2010-04-15

Similar Documents

Publication Publication Date Title
US11221340B2 (en) Lung cancer biomarkers and uses thereof
EP2340506B1 (fr) Biomarqueurs de cancer du poumon et utilisations associées
US10359425B2 (en) Lung cancer biomarkers and uses thereof
US20100221752A2 (en) Ovarian Cancer Biomarkers and Uses Thereof
AU2011289284B2 (en) Pancreatic cancer biomarkers and uses thereof
CA2847188C (fr) Biomarqueurs de cancer du poumon a cellule non petite
US20120143805A1 (en) Cancer Biomarkers and Uses Thereof
US20120165217A1 (en) Cancer Biomarkers and Uses Thereof
US20150160225A1 (en) Renal Cell Carcinoma Biomarkers and Uses Thereof
CA2737004A1 (fr) Biomarqueurs du cancer des ovaires et leurs utilisations
US20220065872A1 (en) Lung Cancer Biomarkers and Uses Thereof

Legal Events

Date Code Title Description
FZDE Discontinued

Effective date: 20151006